Intellia Therapeutics stockNTLA
Intellia Therapeutics trades at $11.10, 39.9% below its 52-week high (Jul 2, 2026). The price is below its 50- and 200-day averages, a downtrend. +23.5% year to date, −18.2% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 5, 2026.
Ratings, candles, signals and the screener for NTLA — after you log in
Open the terminalFrequently asked questions about Intellia Therapeutics
What is the Intellia Therapeutics stock price?
At the close on Nov 5, 2026: $11.10 (−9.83% on the day). 52-week high: $18.48 on Jul 2, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Intellia Therapeutics report earnings?
The next quarterly report is on Nov 5, 2026. Last quarter, earnings per share changed +1% year over year, revenue −48%.
Does Intellia Therapeutics pay dividends?
No, Intellia Therapeutics does not pay dividends.
Where does Intellia Therapeutics trade and how to buy it?
Ticker NTLA, exchange Nasdaq, listed since 2016. You can buy it through a broker with access to US exchanges.
Should I buy Intellia Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for NTLA are in the terminal after you log in.